Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
NCT07224152Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of NBTXR3 in non-small cell lung cancer (NSCLC), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2026; status: recruiting.
02
Drugs
NBTXR3
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07224152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224152.